Press Releases

Date	Title	Company
10-Oct-2023	Merck Announces Pivotal KEYNOTE-671 Trial Meets Dual Primary Endpoint of Overall Survival (OS) in Resectable Stage II, IIIA or IIIB Non-Small Cell Lung Cancer (NSCLC)	Businesswire
10-Oct-2023	Vulvovaginal Candidiasis Treatment Research Report 2023 - ResearchAndMarkets.com	Businesswire
10-Oct-2023	Dental Burs Industry Predicted to Attain US$295.6 Million by 2032, Anchored by a 7.8% CAGR \| FMI Insights	MARKITWIRED
10-Oct-2023	Healthcare Natural Language Processing Industry Thrives with 18.0% CAGR, Targeting US$18.5 Billion by 2033 \| FMI Reveals	MARKITWIRED
10-Oct-2023	eClinical Solutions and Software Industry Soars with 12.1% CAGR, Projected to Reach US$29.1 Billion by 2033 \| FMI	MARKITWIRED
10-Oct-2023	Rancho BioSciences to Showcase CDISC Data Services at the 2023 CDISC US Interchange	Newswire
10-Oct-2023	Eckert & Ziegler and PharmaLogic Sign Reservation Agreement for Supply of Therapeutic Radioisotope Actinium-225	Eckert & Ziegler Strahlen- und Medizintechnik AG
10-Oct-2023	BioMap Establishes a Strategic Collaboration with Sanofi to Co-Develop AI Modules to Accelerate Drug Discovery for Biotherapeutics	Businesswire
10-Oct-2023	Patient Engagement Platforms Industry Predicted to Hit US$93.4 Billion by 2032, with an expected 17% CAGR	MARKITWIRED
10-Oct-2023	Interim Results from a NanOlogy Phase 2 Clinical Trial of its Intratumoral Investigational Drug in the Treatment of Locally Advanced Pancreatic Cancer	Businesswire
10-Oct-2023	Couragene Co-founders Developing Gene Editing Technology for Genetic Diseases Awarded Major Federal Grant	Businesswire
10-Oct-2023	Sibylla Biotech Appoints Sonia Poli as Chief Scientific Officer	Businesswire
10-Oct-2023	Finalists Named for 2023 ISG Paragon Awards™ EMEA	Businesswire
10-Oct-2023	Theramex Announces Agreement to Acquire the European Rights to Duphaston® and Femoston® From Viatris, Inc.	Businesswire
10-Oct-2023	Bayer Opens First Cell Therapy Manufacturing Facility to Advance Regenerative Medicines on a Global Scale	Businesswire
10-Oct-2023	Centrient Pharmaceuticals joins Almirall’s growing innovation hub in Barcelona	Businesswire
10-Oct-2023	PharmEnable Therapeutics and Sosei Heptares Expand Drug Discovery Collaboration	PharmEnable Therapeutics
10-Oct-2023	Roche’s Vabysmo maintained vision improvements with extended treatment intervals up to four months for people with retinal vein occlusion (RVO) in phase III studies	Roche
10-Oct-2023	TME Pharma Provides Positive Update on 18-Month Survival for NOX-A12 Combination Regimen in Brain Cancer and Provides Strategic Update Including Decision to Engage with US FDA	Businesswire
10-Oct-2023	Transgene and BioInvent - First Patient Treated in Part B of Phase I Trial Assessing the Novel Oncolytic Virus BT-001 in Combination With KEYTRUDA® (pembrolizumab)	Businesswire